Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SNRS- Sunrise Technologies -- Ignore unavailable to you. Want to Upgrade?

To: Joe who wrote (1121)	6/19/1998 8:08:00 PM
From: Joe	Respond to of 4140

"fell" translates to the English word "feel". Duh! I still fell like a mushroom.

To: Joe who wrote (1121)	6/20/1998 5:32:00 AM
From: Joe	Respond to of 4140

The following was clipped from the Yahoo thread and was authored by "Tomoosker": <<Just Return From Red Chip Conference IN NYC; Jun 20 1998, 12:04AM EDT Would like to say that I have some new and exciting news, but alas and alak it is not necessarily so. Still waiting for NASDAQ to relist, all requirments fulfilled by SNRS for doing so. Of the 400 test patients, 390 have been completed. Clinical trial for third stage may be finished in the next month or so. But several months are needed to monitor these patients. After that application will be made to FDA for final approval. This will be helped by the fact that they have hired Dr who have been with the FDA and can anticipate what FDA will want and help steer them through the process. We were told that SNRS will seek FDA approval some time next year. As stated on my post last night the tests so far have been very successful. From my source in Boca Raton, Templeton Mutual Funds and the Arthur Demoss Foundations are waiting to buy after NASDAQ listing "Be not weary in well doing for in due season you shall reap if you faint not." (Gal 6:9) Tomoosker>>